Last Updated On 11/17/2023 12:56:11 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Abbvie |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: Autolus |
| Recipient: You |
| Company: Cellectar |
| Recipient: You |
| Company: ADC Therapeutics |
| Recipient: You |
| Company: Kite/Gilead |
| Recipient: You |
| Company: Ono Pharmaceutical |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Abbvie |
| Recipient: You |
| Company: Astra Zeneca |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
| Company: Autolus |
| Recipient: You |
| Company: Cellectar |
| Recipient: You |
| Company: ADC Therapeutics |
| Recipient: You |
| Company: Kite, a Gilead company |
| Recipient: You |
| Company: Ono Pharmaceutical |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Kite/Gilead |
| Recipient: Your Institution |
| Company: Kymera |
| Recipient: Your Institution |
| Company: Ono Pharmaceutical |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|